| Model Number |
10D89R7 |
| Medical Device Problem Code |
Fluid/Blood Leak (1250)
|
| Health Effect - Clinical Code |
Hemorrhage/Blood Loss/Bleeding (1888)
|
| Date of Event |
07/23/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that during use of a custom tubing pack, it was reported that there was a leak at the y connector from the tubing connection.There was patient blood loss because of the leak but an unplanned blood transfusion was not required because of the blood loss from the leak.The same leak did not appear in multiple packs.The device was used to complete the procedure.There was no adverse patient effect associated with this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Device evaluation summary: visual inspection shows evidence of a leak at one of the "y" connectors.Device was cleaned using a 10% bleach solution.Additional visual inspection shows the tie bands are loose.The tubing was removed and observed under magnification and there is evidence of solvent residue.Pressure integrity testing was performed at 3 l/pm with 23 psi, (1189 mmhg) of back pressure for 10 minutes.During the pressure integrity testing there was a leak observed from the "y" connector/tubing connection.Reason for return was confirmed.Additional information b5.Medtronic received additional information that patient blood loss was minimal.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|